'Three-parent babies' public consultation launched

Vials are prepared for DNA testing in a lab. The British public are being consulted on the ethics of a fertility treatment that uses DNA from a third parent to help eliminate genetic diseases, the government announced on Monday.

The British public are being consulted on the ethics of a fertility treatment that uses DNA from a third parent to help eliminate genetic diseases, the government announced on Monday.

The results of the consultation will help inform a decision by Jeremy Hunt on whether to legalise the treatment as early next year—potentially making Britain the first country in the world to hold human trials into the treatment, the Daily Telegraph reported.

The IVF-based technique is designed to avoid serious inherited on the maternal side, such as , by replacing some of the with healthy DNA from the so-called "third parent".

One in 200 children are born each year with a form of disease in their mitochondrial DNA, the structures within cells that convert energy from food into a form that the body can use.

Many of those children have mild to no symptoms, and may never even have the disease diagnosed, the Human Fertilisation and Embryology Authority, which is overseeing the consultation, said in a press statement.

Others can have severe, even life-shortening symptoms such as muscular weakness or heart disease. The Telegraph reported that up to one in 6,500 people born in Britain each year suffer severe symptoms.

Scientists are developing a technique to remove some of the mitochondrial DNA of the mother and replace it with DNA from the "third parent" to create a healthy embryo.

The technique is currently lawful in a laboratory but the embryos cannot be used in treatment, the HFEA said, calling the treatment "uncharted territory".

"Any child born following mitochondria replacement would share DNA with three people, albeit a tiny amount with the donor," the organisation said in a statement. "These changes would affect the germ line, meaning the donor's mitochondrial DNA would be passed on to ."

"We will use our considerable experience of explaining complicated areas of science and ethics to the public to generate a rich debate that is open to all," chairman Lisa Jardine said in a press release.

She stated: "We find ourselves in uncharted territory, balancing the desire to help families have healthy children with the possible impact on the children themselves and wider society."

Jardine called the decision one of "enormous public interest".

It furthers the debate on "designer babies" and the morality of engineering first fuelled by the original forays into IVF treatment.

There are also fears over how the "third parent" would affect the child's sense of identity, and what rights both the child and the third parent would have.

The consultation will run until December 7, with the public encouraged to discuss whether the clinical benefits outweigh any moral, ethical or other health concerns via the HFEA website at www.hfea.gov.uk/ .

Related Stories

Mitochondrial technique is ethical

date Jun 12, 2012

(Medical Xpress) -- An influential independent body has found that a pioneering mitochondrial transfer technique is ethical. Developed by a team at Newcastle University, the technique aims to prevent the transmission of maternally ...

UK group: New embryo methods should be allowed

date Jun 11, 2012

(AP) — An influential British bioethics group says that couples who face the risk of having a baby with certain genetic diseases should be allowed to use eggs from two women to produce the embryo.

Recommended for you

German woman, 65, gives birth to quadruplets

date May 23, 2015

A 65-year-old teacher from Berlin has given birth to quadruplets after a pregnancy that was widely criticized by medical professionals because of her age, RTL television said Saturday.

More evidence C-sections riskier for moms

date May 20, 2015

(HealthDay)—Women who deliver their first baby by cesarean section are more likely to need blood transfusions and be admitted to intensive care units than women who opt for a vaginal delivery, U.S. health ...

Meds offer slight symptom relief in overactive bladder

date May 20, 2015

(HealthDay)—For women with overactive bladder, medications delivered as a daily dose correlate with small reductions in urge incontinence episodes and voiding, according to a review published online May ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Tausch
Sep 17, 2012
The forensics of DNA must adapt to chimeric research.
Chimeric research vows to change the evolution of genetics.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.